What Are the Best Endpoints for Trials of Agents for Ulcerative Colitis?
Despite advances in methods of clinical trials for ulcerative colitisĀ (UC), there is still a large amount of variation in endpoints, even in definitions of response and remission, reseachers found in a systematic review published in the May issue of Clinical Gastroenterology and Hepatology. The authors conclude that we need a
Read more